Furthermore, p53 autoantibodies have been shown to detect ovarian/tubal cancers in women with ovarian /tubal cancers which do not express CA125 (16% and many months prior to diagnosis, lead time of 22 months).13 This evidence concerns the gene TP53 and fallopian tube cancer.